Absher Wealth Management, LLC Abbott Laboratories Transaction History

Absher Wealth Management, LLC

$752 Million
Q3 2024

A detailed history of Absher Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Absher Wealth Management, LLC holds 175,732 shares of ABT stock, worth $20.2 Million. This represents 2.66% of its overall portfolio holdings.

Number of Shares

175,732

Previous 183,839 4.41%

Holding current value

$20.2 Million

Previous $19.1 Million 4.88%

% of portfolio

2.66%

Previous 2.77%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $811,267 - $957,679	-8,107 Reduced 4.41%	175,732 $20 Million
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $85,922 - $95,911	853 Added 0.47%	183,839 $19.1 Million
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $229,663 - $253,653	-2,097 Reduced 1.13%	182,986 $20.8 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $199,861 - $244,646	2,216 Added 1.21%	185,083 $20.4 Million
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $804,649 - $965,444	8,423 Added 4.83%	182,867 $17.7 Million
Q2 2023 Jul 18, 2023	BUY	$100.78 - $112.29 $152,883 - $170,343	1,517 Added 0.88%	174,444 $19 Million
Q1 2023 Apr 17, 2023	BUY	$96.86 - $114.01 $1,840 - $2,166	19 Added 0.01%	172,927 $17.5 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $573,401 - $672,688	6,032 Added 3.61%	172,908 $19 Million
Q3 2022 Oct 19, 2022	BUY	$96.76 - $112.03 $124,143 - $143,734	1,283 Added 0.77%	166,876 $16.1 Million
Q2 2022 Jul 25, 2022	BUY	$102.07 - $123.37 $221,389 - $267,589	2,169 Added 1.33%	165,593 $18 Million
Q1 2022 Apr 14, 2022	BUY	$114.02 - $139.04 $189,045 - $230,528	1,658 Added 1.02%	163,424 $19.3 Million
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $18,369 - $22,492	-159 Reduced 0.1%	161,766 $22.8 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $154,691 - $171,133	-1,326 Reduced 0.81%	161,925 $19.1 Million
Q2 2021 Aug 03, 2021	BUY	$105.79 - $124.53 $3.44 Million - $4.04 Million	32,481 Added 24.84%	163,251 $18.9 Million
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $263,175 - $310,060	2,418 Added 1.88%	130,770 $15.7 Million
Q4 2020 Feb 01, 2021	BUY	$105.0 - $114.42 $570,360 - $621,529	5,432 Added 4.42%	128,352 $14.1 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $74,961 - $91,035	-818 Reduced 0.66%	122,920 $13.4 Million
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $348,316 - $445,802	4,549 Added 3.82%	123,738 $11.3 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $215,095 - $314,528	3,424 Added 2.96%	119,189 $9.41 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $9.09 Million - $10.1 Million	115,765 New	115,765 $10.4 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Absher Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Absher Wealth Management, LLC with notifications on news.

Account

Absher Wealth Management, LLC Abbott Laboratories Transaction History